Pharma news
Pharma
Judge says lower court abused discretion when issuing injunction | Negative impact of potential Medtronic deal on Insulet was “mere conjecture”. 18 June 2024
Pharma
New Jersey court grants 30-day stay days after ordering the removal of five patents for asthma inhalers from FDA Orange Book | Decision follows ruling favouring Amneal Pharmaceuticals, which argued the patents were improperly listed. 18 June 2024
Pharma
New counsel previously worked in-house at major pharmaceutical firm | Ex-Fenwick & West attorney has advised clients in areas including gene editing and antibodies. 13 June 2024
Pharma
Court grants temporary restraining order against defendants following Roche allegations | Company claims India-based counterfeiters selling low-quality diabetes test products on Amazon. 13 June 2024
Pharma
Victory for Amneal Pharmaceuticals as court dismisses infringement claims | Decision orders Teva to remove patents covering its breathing drug from the FDA's Orange Book | Paves the way for Amneal's generic version. 11 June 2024
Pharma
Swiss multinational claims Trividia infringed two patents | Roche says former employees with knowledge of patents joined Sinocare subsidiary. 6 June 2024
Pharma
Delaware judge denies DexCom’s motion to dismiss two counter-counterclaims in complex dispute with rival Abbott over glucose monitors | But judge also says Abbott is not entitled to further remedy. 4 June 2024
Pharma
US Senate committee accuses drug companies of ‘gaming’ the patent system | Industry representatives interrogated during hearing | ‘Playing games with patents has to stop’, says one Senator. 23 May 2024
Europe
As the company challenges Pfizer and BioNTech over COVID-19 vaccine patents, issues over the enforceability of pledges made during the pandemic may make pharma think twice in future, finds Marisa Woutersen. 16 May 2024
Americas
An LSPN panel discusses the challenges and strategies for effective collaboration between in-house counsel and outside legal teams, stressing the importance of communication, strategic planning, and clear expectations. 14 May 2024